Data from multiple sources - Curated by Marshall Pearce - Last updated 06 June 2017

Other skin disorders

Even mild skin disease can cause significant distress for patients, due to associated visibility and stigma, and this is of particular relevance for conditions which affect

...


Read more on Other skin disorders

 

 

Latest news articles

Added 2 months ago Drug news

European Commission approves Imraldi, a biosimilar referencing Humira (adalimumab) to treat the originator drug indications- Biogen.

Samsung Bioepis Co., Ltd. announced the European Commission’s (EC) approval of Imraldi, a biosimilar referencing Humira (adalimumab), for the treatment...

Added 4 months ago Drug news

Nucala (mepolizumab) filed with FDA as an add-on therapy to corticosteroids for the treatment of adult patients with Eosinophilic Granulomatosis with Polyangiitis- GlaxoSmithKline

GlaxoSmithKline announced the submission of a supplemental Biologics License Application (sBLA) to the United States Food and Drug Administration (FDA),...

Added 5 months ago Drug news

Phase III study of Nucala (mepolizumab) in Eosinophilic Granulomatosis with Polyangiitis published in NEJM- GlaxoSmithKline

GlaxoSmithKline has announced publication in the New England Journal of Medicine, of a randomised, double-blind, placebo controlled study investigating the...

Search all news articles for Other skin disorders
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

+ 7 more

IL-17A in Psoriasis

IL-17A in Psoriasis

Experts discuss new targeted therapies for psoriasis at the European Association of Dermatology and Venereology (EADV) Congress.

+ 1 more

Fabry Disease

Fabry Disease

Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A

Load more

Guidelines

Canadian Guidelines for the Management of Plaque Psoriasis 2009

Since the publication of the 2009 Canadian Guidelines for the Management of Plaque Psoriasis, significant advances have been made in determining the role of T cells in inflammatory and autoimmune diseases. 

Added 9 months ago

Adalimumab for treating moderate to severe hidradenitis suppurativa

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Added 9 months ago

European S3-Guidelines on the systemic treatment of psoriasis vulgaris

In recognition of the impact of psoriasis on patients the World Health Assembly (WHA) in May 2014 supported including psoriasis into the group of non-communicable diseases.

Added 9 months ago

Search all guidelines for Other skin disorders
 

Journal articles

A novel nicastrin mutation in a three generation Dutch family with hidradenitis suppurativa

Hidradenitis suppurativa (HS) compromises a multifactorial pathogenesis with a largely unclear aetiology. 

Added 4 months ago

Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a serious, debilitating, chronic inflammatory skin disease.

Added 4 months ago

Search all journal articles for Other skin disorders
 

Clinical trials

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

The objective of this study is to evaluate the safety profile of Adalimumab for Hidradenitis Suppurativa (HS) participants in normal medical practice.

Added 9 months ago

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting.

Added 9 months ago

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study) (SHARPS)

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

Added 9 months ago

Search all clinical trials for Other skin disorders
 
Liam Farrell

Dr Liam Farrell is from Rostrevor in Northern Ireland. He was a family doctor in Crossmaglen, Northern Ireland and a tutor in palliative care. An award-winning satirical columnist and broadcaster, his current columns include the British Medical Journal and GP. He is a member of the ... Read more

Bad smells are good

Delicacy is not a virtue in this job.

CME

Dermatological emergencies in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Emergencies in dermatology

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

Management of hidradenitis suppurativa

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Other skin disorders